| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-17 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-14 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.07 |